Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 1 5Phase 3 4Phase 1/2 4Phase NA 1Phase 4 1

Status

Recruiting 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 6Head & Neck 4Thoracic 2Other hematologic neoplasm 1Lymphoid 1Dermatologic 1Breast 1

Conditions

Nasopharyngeal Carcinoma 3Nasopharyngeal Cancinoma (NPC) 1

Interventions

Cisplatin 144Radiotherapy 71Fluorouracil 50Radiotherapy, Intensity-Modulated 45Docetaxel 39Gemcitabine 38Cetuximab 38Carboplatin 31pembrolizumab 25Capecitabine 22Drug Therapy 17toripalimab 14Paclitaxel 14camrelizumab 10Surgical Procedures, Operative 10Nivolumab 10Chemoradiotherapy 10nimotuzumab 9Radiation 9Neoadjuvant Therapy 8Methotrexate 8Magnetic Resonance Spectroscopy 8Chemotherapy, Adjuvant 8nedaplatin 7Thyrotropin Alfa 7Platinum 7tislelizumab 6spartalizumab 6Standard of Care 6Specimen Handling 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Immune Checkpoint Inhibitors × Head & Neck × Clear all
NCT07590024 2026-06-04

RAIRI-NPC

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 3 Recruiting
651 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT05941741 2026-05-11

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Sun Yat-sen University

Phase 3 Recruiting
380 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT07238569 2025-11-20

Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 3 Not yet recruiting
516 enrolled
Head & Neck

Nasopharyngeal Cancinoma (NPC)

NCT04907370 2025-07-16

DIAMOND

Sun Yat-sen University

Phase 3 Active not recruiting
532 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡